Masataka Shinoda Takafumi Ando Emad M El-Omar Hitomi Takashi Takahisa Suzuki Mutsumi Murayama Kazuhiro Morise Hidemi Goto
10.1371/journal.pone.0038652
PLoS One
2012;7(6):e38652.
CC BY
https://pubmed.ncbi.nlm.nih.gov/22761692/
Adenocarcinoma / drug therapy Antineoplastic Combined Chemotherapy Protocols / therapeutic use Liver Neoplasms / drug therapy Stomach Neoplasms / drug therapy
Adenocarcinoma / drug therapy Antineoplastic Combined Chemotherapy Protocols / therapeutic use Liver Neoplasms / drug therapy Stomach Neoplasms / drug therapy Case Reports Adenocarcinoma / mortality Adenocarcinoma / secondary Aged Aged, 80 and over Cisplatin / administration & dosage Clinical Trials, Phase II as Topic Drug Combinations Female Humans Liver Neoplasms / mortality Liver Neoplasms / secondary Male Middle Aged Oxonic Acid / administration & dosage Prognosis Stomach Neoplasms / mortality Stomach Neoplasms / pathology Survival Rate Tegafur / administration & dosage Drug Combinations S 1 (combination) Tegafur Oxonic Acid Cisplatin
PMC3383684
22761692
Programmed chemotherapy for patients with metastatic unresectable gastric cancer
2012